Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Geisslinger

Showing results (21-30 of 441) with videos related to

Pageof 45
Sort By:
Schmerz (Berlin, Germany)|September 4, 2019
[Generating knowledge from complex data sets in human experimental pain research]Jörn Lötsch, Gerd Geisslinger, Carmen Walter
Expert Opinion on Investigational Drugs|November 15, 2016
Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory painSabine Grösch, Ellen Niederberger, Gerd Geisslinger
European Journal of Pain (London, England)|June 30, 2010
Epigenetics in pain and analgesia: an imminent research fieldAlexandra Doehring, Gerd Geisslinger, Jörn Lötsch
Trends in Pharmacological Sciences|February 25, 2012
Sniffing out pharmacology: interactions of drugs with human olfactionJörn Lötsch, Gerd Geisslinger, Thomas Hummel
Trends in Neurosciences|May 6, 2009
No NO, no pain? The role of nitric oxide and cGMP in spinal pain processingAchim Schmidtko, Irmgard Tegeder, Gerd Geisslinger
Progress in Lipid Research|December 3, 2011
Chain length-specific properties of ceramidesSabine Grösch, Susanne Schiffmann, Gerd Geisslinger
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 21, 2005
LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of ratsRonald Schmidt, Ovidiu Coste, Gerd Geisslinger
Pain|June 29, 2005
Is morphine-3-glucuronide of therapeutic relevance?Carsten Skarke, Gerd Geisslinger, Jörn Lötsch
Schmerz (Berlin, Germany)|April 25, 2020
[Pain models and clinical pain research are not contradictory]Jörn Lötsch, Gerd Geisslinger, Carmen Walter
Genomics|October 16, 2003
Simultaneous screening for three mutations in the ABCB1 geneJörn Lötsch, Carsten Skarke, Gerd Geisslinger
Pageof 45

Showing results (21-30 of 441) with videos related to

Sort By:
Pageof 45
Schmerz (Berlin, Germany)|September 4, 2019
[Generating knowledge from complex data sets in human experimental pain research]Jörn Lötsch, Gerd Geisslinger, Carmen Walter
Expert Opinion on Investigational Drugs|November 15, 2016
Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory painSabine Grösch, Ellen Niederberger, Gerd Geisslinger
European Journal of Pain (London, England)|June 30, 2010
Epigenetics in pain and analgesia: an imminent research fieldAlexandra Doehring, Gerd Geisslinger, Jörn Lötsch
Trends in Pharmacological Sciences|February 25, 2012
Sniffing out pharmacology: interactions of drugs with human olfactionJörn Lötsch, Gerd Geisslinger, Thomas Hummel
Trends in Neurosciences|May 6, 2009
No NO, no pain? The role of nitric oxide and cGMP in spinal pain processingAchim Schmidtko, Irmgard Tegeder, Gerd Geisslinger
Progress in Lipid Research|December 3, 2011
Chain length-specific properties of ceramidesSabine Grösch, Susanne Schiffmann, Gerd Geisslinger
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 21, 2005
LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of ratsRonald Schmidt, Ovidiu Coste, Gerd Geisslinger
Pain|June 29, 2005
Is morphine-3-glucuronide of therapeutic relevance?Carsten Skarke, Gerd Geisslinger, Jörn Lötsch
Schmerz (Berlin, Germany)|April 25, 2020
[Pain models and clinical pain research are not contradictory]Jörn Lötsch, Gerd Geisslinger, Carmen Walter
Genomics|October 16, 2003
Simultaneous screening for three mutations in the ABCB1 geneJörn Lötsch, Carsten Skarke, Gerd Geisslinger
Pageof 45